The deepest body of mechanistic work on GHK-Cu has come from Loren Pickart and collaborators, who have published extensively on its biology across more than four decades (Pickart et al., 2015) In preclinical research, GHK-Cu has been associated with effects on collagen and glycosaminoglycan synthesis in dermal fibroblast models, on hair-follicle morphology in rodent and ex-vivo skin studies, and on expression of genes involved in tissue remodeling
Peter de Keizer's pioneering research at Erasmus University Medical Center to its current status as a leading senolytic research tool, FOXO4-DRI demonstrates how precise molecular targeting can enable selective elimination of harmful cellular populations while preserving healthy tissue function
Research interest includes adipose-tissue research models, NAD+ salvage pathway studies, and metabolic-research applications
They are resistant to proteolytic degradation by cellular proteases and can be easily separated based on their density with a high expression level as compared to other cellular proteins
DPP-IV cleaves incretins, preventing insulin release